Please tell us about your experience with the current COVID-19 Pandemic in your hospital?
As
in most hospitals, the current pandemic has had a significant impact on how the
hospital is operated. The Department of Neurology was organised according to… Continue Reading
Biomedical Alliance in Europe Calls for Strong Health Funding in Next EC Multiannual Financial Framework
November 6, 2025
BioMed Alliance and 17 other civil society organisations call on policy makers to ensure that the next multiannual EU budget will be fit-for-purpose to address current and future health threats.
Latest Posts
-
-
Resident and Research FellowsEAN NewsCOVID-19Top Articles
COVID-19 – RRFS representative report: the Netherlands
April 27, 2020Please tell us about your experience with the current COVID-19 pandemic in your hospital With over 27.000 positively tested patients in the Netherlands, all hospitals had to make major adaptations to their general practice. Non-urgent care has been put on… Continue Reading -
Resident and Research FellowsEAN NewsCOVID-19Top Articles
COVID-19 – RRFS representative report: Italy
April 27, 2020Italy has been the first European country to be violently hit by the ongoing pandemic of COVID-19. Whilst devastating, luckily the measures undertaken- although considered draconian by some- avoided greater spread across the whole nation. The areas where the first… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Miller Fisher Syndrome and polyneuritis cranialis in COVID-19
April 22, 2020In this article recently published in Neurology, Gutiérrez-Ortiz et al., report two patients infected with SARS-CoV-2 who presented with Miller Fisher syndrome and polyneuritis cranialis, respectively. The first patient was a 50-year-old man who presented with anosmia, ageusia, right internuclear… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
April 22, 2020It has been already reported that COVID-19 infection may predispose patients to thrombotic disease, both in the venous and arterial circulations, due to excessive inflammation, platelet activation, endothelial dysfunction, and stasis. In addition, many patients receiving antithrombotic therapy for thrombotic… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Guillain–Barré Syndrome Associated with SARS-CoV-2
April 22, 2020In this report, the authors examined five patients who had Guillain–Barré syndrome after the onset of coronavirus disease 2019 (Covid-19) infection. Four of the patients had a positive nasopharyngeal swab for SARS-CoV-2 at the onset of the neurologic syndrome, while… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Neurologic Features in Severe SARS-CoV-2 Infection
April 22, 2020In this study, recently published in the New England Journal of Medicine, the authors report the neurologic features in an observational series of 58 of 64 consecutive patients admitted to two intensive care units (ICUs) in Strasbourg, France, because of… Continue Reading -
Anna Bersano and Natan Bornstein on behalf of EAN Stroke Management Panel According to the WHO, the spread of coronavirus disease 2019 (COVID-19) has already reached pandemic proportion, affecting at present more than 2.034.000 patients worldwide. Although the majority of… Continue Reading
-
EAN NewsCOVID-19Top Articles
COVID-19: statement by the Autonomic nervous system disorders Scientific Panel
April 17, 2020The ongoing COVID-19 outbreak raises new management challenges, which lack an evidence-based answer to date. The management group of the EAN Scientific Panel for Autonomic Nervous System (ANS) Disorders discusses below some management aspects relevant to patients with autonomic disorders.… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
April 17, 2020COVID-19 AND NEUROLOGY In this useful consensus paper, the current clinical guidelines and research progress on the management of COVID-19 are summarized, emphasizing on its neurological manifestations. The aim of consensus was to help neurologists to understand the occurrence, development… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Headaches Associated with Personal Protective Equipment – A Cross-sectional Study Amongst Frontline Healthcare Workers During COVID-19 (HAPPE Study)
April 17, 2020COVID-19 AND NEUROLOGY During the COVID-19 outbreak, frontline healthcare workers were mandated to wear personal protective equipment (PPE) while caring for suspected or confirmed COVID-19 patients, which involved the donning of face masks, protective eyewear, gowns, surgical gloves and the… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic.
April 17, 2020COVID-19 AND NEUROLOGY Because most patients with MG are on immunosuppressive or immunomodulatory therapies and may also have respiratory muscle weakness, there is a theoretical concern that MG/LEMS patients may be at higher risk of contracting the infection or experiencing… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Olfactory and gustatory dysfunctions as a clinical presentation of mild‐to‐moderate forms of the coronavirus disease (COVID‐19): a multicenter European study
April 17, 2020COVID-19 AND NEUROLOGY The aim of this multicenter study was to investigate and characterize the occurrence of olfactory and gustatory disorders in patients with laboratory-confirmed COVID-19 infection. A total of 417 mild-to-moderate COVID-19 patients were included in the study; in… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Compassionate Use of Remdesivir for Patients with Severe Covid-19
April 17, 2020COVID-19 TREATMENT In this report, the authors describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis. Remdesivir is a prodrug of a nucleotide analogue that is intracellularly metabolized to… Continue Reading -
Breaking newsEAN NewsCOVID-19Top Articles
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
April 17, 2020COVID-19 TREATMENT In this nice narrative review just published in JAMA, the authors summarize current evidence regarding major proposed treatments, repurposed or experimental, for COVID-19 and provides a summary of current clinical experience and treatment guidance for this novel epidemic… Continue Reading









